Back to News
Market Impact: 0.15
Processa Pharmaceuticals, Inc. Appoints Gregory J. Flesher as Chief Operating Officer and Announces Key Leadership Additions
Source: Nasdaq
Management & GovernanceHealthcare & BiotechCompany Fundamentals
Processa Pharmaceuticals’ board approved Gregory J. Flesher’s appointment as chief operating officer, effective November 4, 2026. His employment letter provides for an annual base salary of $700,000; the article text is truncated before details of any additional compensation.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
PCSA0.10
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Inside the chip talent war: Trade secrets and rising Chinese rivals
- Snap shares fall over 10% on third-quarter earnings miss
- Host Hotels & Resorts CEO on 3Q Quarterly Results